Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

NST-SPARK: Preliminary Study of an Augmented Reality (AR) App Delivering Recovery-Oriented Cognitive Therapy for Negative Symptoms in Schizophrenia

NCT06653829 is registered in ClinicalTrials.gov with North Shore Therapeutics, Inc. as lead sponsor.

NCT NCT06653829
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06653829 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
NST-SPARK: Preliminary Study of an Augmented Reality (AR) App Delivering Recovery-Oriented Cognitive Therapy for Negative Symptoms in Schizophrenia
Lead sponsor
North Shore Therapeutics, Inc.
Phase
Not applicable
Overall status
Completed
Start date
November 6, 2023
Completion date
August 31, 2024
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

negative symptoms in schizophrenia, schizoaffective disorder, schizophrenia